Outcomes of Ultrasound-Guided Foam Sclerotherapy for Varicose Veins of the Lower Extremities: A Single Center Experience

2011 ◽  
Vol 37 (6) ◽  
pp. 804-809 ◽  
Author(s):  
ATSUMORI HAMAHATA ◽  
TAKASHI YAMAKI ◽  
HIROYUKI SAKURAI
2017 ◽  
Vol 22 (4) ◽  
pp. 137-142 ◽  
Author(s):  
Tomasz Zubilewicz ◽  
Piotr Terlecki ◽  
Karol Terlecki ◽  
Stanislaw Przywara ◽  
Janusz Rybak ◽  
...  

2011 ◽  
Vol 37 (6) ◽  
pp. 804-809
Author(s):  
ATSUMORI HAMAHATA ◽  
TAKASHI YAMAKI ◽  
HIROYUKI SAKURAI

2021 ◽  
Vol 93 (6) ◽  
pp. AB211-AB212
Author(s):  
Abhishek Bhurwal ◽  
Mihajlo Gjeorgjievski ◽  
Peter Dellatore ◽  
Amy Tyberg ◽  
Haroon M. Shahid ◽  
...  

2009 ◽  
Vol 24 (4) ◽  
pp. 183-188 ◽  
Author(s):  
P Chapman-Smith ◽  
A Browne

Objectives The purpose of this study was to determine the long-term efficacy, safety and rate of recurrence for varicose veins associated with great saphenous vein (GSV) reflux treated with ultrasound-guided foam sclerotherapy (UGFS). Methods A five-year prospective study was performed, recording the effect on the GSV and saphenofemoral junction (SFJ) diameters, and reflux in the superficial venous system over time. UGFS was the sole treatment modality used in all cases, and repeat UGFS was performed where indicated following serial annual ultrasound. Results No serious adverse outcomes were observed – specifically no thromboembolism, arterial injection, anaphylaxis or nerve damage. There was a 4% clinical recurrence rate after five years, with 100% patient acceptance of success. Serial annual duplex ultrasound demonstrated a significant reduction in GSV and SFJ diameters, maintained over time. There was ultrasound recurrence in 27% at 12 months, and in 64% at five years, including any incompetent trunkal or tributary reflux even 1 mm in diameter being recorded. Thirty percent had pure ultrasound recurrence, 17% new vessel reflux and 17% combined new and recurrent vessels on ultrasound. Of all, 16.5% required repeat UGFS treatment between 12 and 24 months, but less than 10% in subsequent years. The safety and clinical efficacy of UGFS for all clinical, aetiological, anatomical and pathological elements classes of GSV reflux was excellent. Conclusion The popularity of this outpatient technique with patients reflects ease of treatment, lower cost, lack of downtime and elimination of venous signs and symptoms. Patients accept that UGFS can be repeated readily if required for recurrence in this common chronic condition. The subclinical ultrasound evidence of recanalization or new vein incompetence needs to be considered in this light.


Pancreatology ◽  
2018 ◽  
Vol 18 (4) ◽  
pp. S43-S44
Author(s):  
Peter Macinga ◽  
Karel Poc ◽  
Petr Stirand ◽  
Pavel Wohl ◽  
Pavel Drastich ◽  
...  

2011 ◽  
Vol 27 (1) ◽  
pp. 19-24 ◽  
Author(s):  
R H Bhogal ◽  
C E Moffat ◽  
P Coney ◽  
I K Nyamekye

Objective We assessed the use of ultrasound guided foam sclerotherapy (UGFS) to treat bilateral varicose veins either as synchronous or interval procedures. We specifically assessed total foam volume usage and its influence on early outcome and complications. Methods We reviewed our prospectively compiled computerised database of patients with bilateral varicose veins who have undergone UGFS. Duplex findings, foam volumes used and clinical outcome were assessed. Results One hundred and twelve patients had undergone UGFS for bilateral varicose veins. Sixty-one had bilateral UGFS (122 legs) and 51 had interval UGFS (102 legs). Seventy-eight percent bilateral and 60% interval procedures were for single trunk disease. Median foam volumes per treatment episode were: 17.5 mls bilateral, and 10 mls interval FS. At two weeks 81% of legs had complete occlusion after bilateral UGFS compared to 70% after interval UGFS. One patient in the bilateral UGFS developed transient visual disturbance. There was no systemic complications in the interval UGFS. Conclusions Bilateral foam sclerotherapy treatment did not adversly affect vein occlusion rates and there was no significant difference in complication rates between the two groups. Bilateral UGFS can be safely performed in selected patient presenting with bilateral varicose veins.


Sign in / Sign up

Export Citation Format

Share Document